MAI Therapeutics
East Lansing
About MAI Therapeutics
MAI Therapeutics engages in the design and development of a generative network platform based on mathematical artificial intelligence software to identify potential drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Pre-Seed (Aug 2021)
- Website: maitherapeutics.com
Industries & Categories
Artificial Intelligence (AI), Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/mai-therapeutics-3508201 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.